Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully ...

Thyssenkrupp nucera AG & Co. KGaA (Dortmund, Germany) has been commissioned to carry out a Front-End Engineering Design (FEED ...

First visit to the USABVB's first trip to the USA back in May 1954 lasted for several weeks. Their opponents in North America ...

Merck KGaA, based in Darmstadt, Germany, funded the research. Morand reported financial relationships with 17 pharmaceutical companies, several of which manufacture lupus drugs.

Maximilian Beier was on the training ground in Dortmund-Brackel long before his team-mates on Monday afternoon. The Borussia ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

Merck KGaA’s antibody-drug conjugate (ADC), precemtabart tocentecan, has shown to be safe and tolerable in a Phase Ib trial.

Connected drug delivery devices integrate digital connectivity — often via Bluetooth — with traditional drug administration ...

Merck KGaA (OTC:MKGAF) is seeking worldwide regulatory approval for its CSF-1R inhibitor pimicotinib following robust Phase ...

In the latest instalment of a long-running dispute, the Court of Appeal has recently upheld the High Court judge's view on ...

In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...